Glybera
alipogene tiparvovec
Hyperlipoproteinemia Type I
Date of authorisation:
Revision: 8
Last updated:
MedicineHumanExpired
EMEA-000292-PIP01-08-M03 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Cardiovascular diseases
PIP number: P/0285/2016
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001712-PIP02-15 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Neurology
PIP number: P/0077/2016
Route(s) of administration: Oral use
Pharmaceutical form(s):
Capsule (hard)
Decision date:
Last updated:
Compliance check: ✖
PIPHuman